Gregory Piazza on Insights for COVID19 Patients in the CORONA-VTE Network Study
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared on LinkedIn:
”So excited to share the publication in JAHA of this long-term project focused on Adjudicated Cardiovascular Events in Patients with COVID-19, the CORONA-VTE Network Study.
While many studies have relied upon large dataset analyses and diagnosis codes to understand the impact of COVID-19, we chose to create a large unique multicenter registry with adjudicated endpoints providing data from the start of the pandemic to 2024.
What did we find?
The hazard of cardiovascular events has not diminished, contrary to other reports, AND vaccination is associated with reduced risk.
So proud of our research team and collaborators across the CORONA-VTE Network.”
Read the full article here.
Article: Adjudicated Cardiovascular Events in Patients With COVID‐19: Association With Vaccination Status and Changes over Time
Authors: the CORONA‐VTE Network Investigators

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments